Title: Lessons learned from Phase 1 trial of heart-derived stem cells as we move into Phase 2 Speaker: Eduardo Marbán, M.D., Ph.D. Founder and Chairman of Scientific Advisory Board, Capricor,…
One percent of live births have heart defects, the leading noninfectious cause of death in the 1st year. Using embryonic stem cell technology, Dr. Deepak Srivastava's lab has made many…
Long-term stem cell-based strategies for heart disease aim to rebuild parts of the heart. But investigators like Deepak Srivastava are also looking into more near term goals to regenerate heart…
The day before 9/11, just four months pregnant, Mary Goulart and her husband learned through ultrasounds that their baby had several heart defects including a missing left ventricle. After birth,…
CIRM has funded a $5.5 million Disease Team to develop a follow-on cardiac stem cell clinical trial that uses a patient's own heart stem cells to regenerate scarred tissue damaged…
Robert Klein, J.D. and Claire Pomeroy, M.D., M.B.A., gave the welcoming remarks for the "Spotlight on Cardiovascular Therapies," an educational event presented at the California Institute for Regenerative Medicine Governing…
"Cardiac Tissue Regeneration and Biosurgery" On March 10, 2011, W. Douglas Boyd, M.D., spoke about his work towards developing stem cell-based technologies to repair heart tissue damaged by cardiovascular disease.…
"Stem Cell Research: Where are we with Peripheral Arterial Disease (PAD)" On March 10, 2011, Yung-Wei Chi, D.O., spoke about a recently launched clinical trial that using a patient's own…
"Patient Advocate Speaker" On March 10, 2011, Jeanette Owens spoke about living with peripheral arterial disease and about her hopes for stem cell treatments. Owens was introduced by Claire Pomeroy,…
